The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2022

Filed:

Mar. 03, 2017
Applicant:

Public University Corporation Nagoya City University, Nagoya, JP;

Inventors:

Takahiro Iwao, Nagoya, JP;

Tomoki Kabeya, Nagoya, JP;

Tamihide Matsunaga, Nagoya, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); G01N 33/50 (2006.01); C12N 5/071 (2010.01); C12N 5/16 (2006.01); A61L 27/00 (2006.01); C12N 5/074 (2010.01); A61K 35/38 (2015.01);
U.S. Cl.
CPC ...
G01N 33/5044 (2013.01); A61L 27/00 (2013.01); C12N 5/0679 (2013.01); C12N 5/0696 (2013.01); C12N 5/16 (2013.01); G01N 33/5073 (2013.01); A61K 35/38 (2013.01); C12N 2501/01 (2013.01); C12N 2501/11 (2013.01); C12N 2501/115 (2013.01); C12N 2501/15 (2013.01); C12N 2501/727 (2013.01); C12N 2506/45 (2013.01);
Abstract

An object of the present invention is to provide a novel method which enables convenient preparation of cells exhibiting functions close to that of intestinal epithelial cells of living bodies, and use of the method. The differentiation of induced pluripotent stem cells into intestinal epithelial cells is induced by step of differentiating induced pluripotent stem cells into endoderm-like cells; step of differentiating the endoderm-like cells obtained in step into intestinal stem cell-like cells; and step of differentiating the intestinal stem cell-like cells obtained in step into intestinal epithelial cell-like cells, wherein step includes culture in the presence of a MEK1 inhibitor, a DNA methyltransferase inhibitor, a TGF-β receptor inhibitor, and EGF and under the condition that cAMP is supplied to the cells.


Find Patent Forward Citations

Loading…